S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › 0IU8 › Research report
← 0IU8 page
XStocksXray
Market X-Ray report · 20 October 2026

Safran SA (0IU8)

London Exchange · UK · prices in EUR · close of 20 Oct 2026

Key indicators

Last closeEUR 313.45
52-week range258.62 – 368.90
Return, 1 month / 3 months−5.1% / −4.2%
Return, 1 year / 3 years+2.8% / +118.0%
TrendBelow its 200-day average
RSI (14)39
Volatility (1 year)32.4%
Worst drawdown (1 year)-22.9%
Average daily value traded69.56M EUR
Dividend yield1.1%

Market X-Ray price-based

61/ 100 · High confidence · ahead of 67% of stocks on this exchange
Trend56
Momentum58
Stability (higher is calmer)61
Liquidity87
Income44

Five-year price chart navy: price · brown: 200-day average

67.991462243023802021-102023-012024-042025-072026-10

About the company

Safran is a French aerospace and defence company. It designs and builds aircraft engines, including commercial jet engines made through its partnership with General Electric, and supplies engines for helicopters and military aircraft. It also makes landing gear, wheels and brakes, cabin equipment and avionics, and provides defence electronics and security systems. Its customers are aircraft manufacturers, airlines, helicopter operators and armed forces around the world, and the company is based in France.

The shares are listed on the London Exchange in UK under the code 0IU8, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Safran SA (0IU8) trades on the London Exchange in UK. It last closed at EUR 313.45 on 20 October 2026.

Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,235 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 2.8% and over the last three months it fell 4.2%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Safran SA (0IU8)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend56 · FairMixed trend against its averages.
Above 200-day average-0.9%
From 52-week high-13.7%
Momentum58 · FairTypical recent returns for this exchange.
3-month return-4.2%
6-month return16.4%
12-month return, skipping the last month8.3%
Stability (higher is calmer)61 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)32.4%
Worst drawdown, 1 year (smaller is calmer)-22.9%
Liquidity87 · StrongTrades actively.
Average daily value traded69.56M EUR
Zero-volume days0.0%
Income44 · WeakDividend is small or irregular.
Dividend yield1.1%
Years with dividends5

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Income: Dividend is small or irregular.

Returns

1 week+0.2%
1 month−5.1%
3 months−4.2%
6 months+16.4%
1 year+2.8%
3 years+118.0%
5 years+198.4%

Signals

50-day / 200-day average332.97 / 316.42
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)7.62

Technical summary

DailyStrongly bearish0 bullish · 4 neutral · 12 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

Recent dividends

Ex-dividend dateAmount per share
26 May 2026EUR 3.3500
27 May 2025EUR 2.9000
28 May 2024EUR 2.2000
30 May 2023EUR 1.3500
31 May 2022EUR 0.5000
31 May 2021EUR 0.4300

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026